2020 Revenues ($USD) : $7,369,357,558
2020 Revenues (foreign currencies) : JP¥786,900,000,000
2020 R&D spend : not available
2020 Number of Employees : 7,555
Fiscal Year End : 12/31/2020
Key People : Osamu Okuda, CEO

Under a strategic alliance forged with Roche in 2002, Chugai maintained management independence while gaining the exclusive right to market Roche's products in Japan. Chugai also has access to the Roche Group's research infrastructure and global platform. Chugai boasts unique antibody engineering technologies as it continues to refine its scientific and technological strengths. –CN